Recurrent Inflammatory Myofibroblastic Tumors
Drug | Drug Name | Drug Description |
---|---|---|
DB08865 | Crizotinib | A receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive. |
Drug | Drug Name | Phase | Status | Count |
---|